Scabies and Lice

NATROBA (spinosad) 0.9% topical suspension by Pernix Therapeutics and ParaPRO

Natroba Now Approved for Younger Children with Head Lice

ParaPRO announced that the Food and Drug Administration (FDA) has approved an expanded age range for Natroba (spinosad) Topical Suspension, to include children 6 months of age and older who have pediculosis capitis (head lice).

SKLICE (ivermectin) 0.5% lotion by Sanofi

Sklice Lotion Now Available

Sanofi Pasteur announced that Sklice (ivermectin) Lotion, 0.5%, is now available for the treatment of head lice in patients 6 months of age and older.

Head Lice Beginning to Show Permethrin Resistance

Head Lice Beginning to Show Permethrin Resistance

Although live head lice obtained from school-aged children in Paris remain susceptible to the insecticide malathion, approximately 14% have been found to be resistant to permethrin, suggesting a strong basis for future insecticide resistance.

SKLICE (ivermectin) 0.5% lotion by Sanofi

Sklice Lotion Approved for Head Lice

Sanofi announced that the FDA has approved Sklice (ivermectin lotion) 0.5% for the topical treatment of head lice in patients ≥6 months of age.